Today our Defy portfolio company, Nautilus Biotechnology, began trading on the Nasdaq under the ticker NAUT after its successful merger with the Arya III SPAC. The event and financial outcome is much less important than what Nautilus hopes to achieve: leveraging technology to change the scale of what is possible in proteomics to enable significant…

Nautilus Biotechnology, Inc., a company pioneering a single-molecule protein analysis platform for quantifying the proteome, today announced the completion of its business combination with Arya Sciences Acquisition Corp III (Nasdaq: ARYA; or “Arya III”), a special purpose acquisition company (SPAC) sponsored by Perceptive Advisors. The combined company, Nautilus Biotechnology, Inc. (“Nautilus”), will commence trading shares…

Nautilus Biotechnology is emerging as Seattle’s newest publicly traded company this week, taking advantage of the mania over SPACs to raise $345 million to fuel a new approach that could accelerate biomedical research and transform drug development.

Elevate Security, a leader in human attack surface management, today announced that the company has been recognized as a CyberTech100 company for 2021. The CyberTech100, an annual list of the world’s most innovative CyberTech organizations, recognizes the pioneering companies helping financial institutions combat cyber threats and fraud.

Since launching, Capchase has issued more than $390 million in financing to over 400 companies and expects to grow by 400 percent over the next six months. “The market is crazy,” said Miguel Fernandez, co-founder and CEO. “Founders are flocking to this type of model.”